Infinity Pharmaceuticals Share Based Compensation Trend

INFI -- USA Stock  

USD 2.31  0.09  3.75%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Interest Expense of 1.6 M or Operating Expenses of 277.9 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Share Based Compensation of Infinity Pharmaceuticals with missing and latest data points interpolated. A component of Net Cash Flow from Operations representing the total amount of noncash; equity-based employee remuneration. This may include the value of stock or unit options; amortization of restricted stock or units; and adjustment for officers' compensation. As noncash; this element is an add back when calculating net cash generated by operating activities using the indirect method.
Share Based Compensation10 Years Trend
Increasing
Slightly volatile
 Share Based Compensation 
      Timeline 

Infinity Pharmaceuticals Regression Statistics

Arithmetic Mean 10,054,245
Geometric Mean 7,888,192
Coefficient Of Variation 49.92
Mean Deviation 4,301,942
Median 12,155,000
Standard Deviation 5,019,444
Range 16,792,619
R Value 0.95
R Squared 0.90
Significance 0.00000242
Slope 1,321,565

Infinity Pharmaceuticals Share Based Compensation Over Time

2016-12-31  14,700,000 
2017-12-31  14,700,000 
2018-12-31  17,294,118 

Other Fundumenentals of Infinity Pharmaceuticals

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Infinity Pharmaceuticals Fundamental Drivers

Infinity Pharmaceuticals Fundamental Market Drivers

Forward Price Earnings-4.49
Short Percent Of Float2.56%
Average Daily Volume Last 10 Day220.83k
Shares Short Prior Month1.71M
Average Daily Volume In Three Month444.76k
Date Short InterestAugust 31, 2018
Fifty Day Average2.061
Two Hundred Day Average2.074

Infinity Pharmaceuticals Upcoming Events

Infinity Pharmaceuticals Upcoming Company Events

Upcoming Quarterly ReportFebruary 28, 2017
Next Earnings ReportMay 3, 2017
Please also check analysis of Infinity Pharmaceuticals Correlation with competitors. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com